Menu

Recent Interviews

Nick Mather, CEO, SolGold PLC

Nick Mather
CEO | SolGold PLC
1 King Street, EC2V 8AU London (GB)

emichael@solgold.com.au

+44 20 3823 2125

SolGold CEO Nick Mather on building a major gold and copper mining company


Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


Stephan Dorfmeister, Finance Department, Deep Nature Project GmbH

Stephan Dorfmeister
Finance Department | Deep Nature Project GmbH
Untere Hauptstraße 168, 7122 Gols (AT)

office@deep-nature.at

+43 681 10139055

Like Aurora Cannabis and Canopy Growth, Deep Nature Project GmbH focuses on value chain


14. August 2020 | 08:07 CET

EXMceuticals, Nebelhornbahn, Syzygy - where entry opportunities now exist

  • Investments

While the share prices of a variety of large companies have already returned to pre-Covid-19 price levels, the shares of small and mid-caps are often still trading at significantly lower levels. Here, there may be opportunities with price potential that can offer attractive returns for investors. It may therefore be worthwhile to take a closer look at some business models and companies.

time to read: 3 minutes by Mario Hose


 

With focus on cannabis

EXMceuticals describes itself as a medical cannabis company that firmly believes in the potential health and wellness benefits of hemp and cannabis. The company is an emerging player in the market with high ambitions and the goal to become a major producer of high quality EU GMP cannabis and hemp ingredients. According to its own statements, the management is building an extraction and refining facility of the highest standards near Lisbon, Portugal, which will be dedicated to the production of cannabis material with API quality active pharmaceutical ingredients. The company is focused on providing the right ingredients for customers in the medical and wellness industry.

EXMceuticals recently announced that loans totaling CAD 4,605,171 were converted into 23,025,855 new shares of the company. The conversion price was CAD 0.20 per share. All shares are subject to a four-month hold period expiring on November 25, 2020. According to the announcement, Jonathan Summers, CEO of the Company, also took advantage of the loan conversion offer and received 11,270,855 shares, representing approximately 16.4% of the company.

Strengthening of market position and business model

The Nebelhornbahn-AG was founded in 1927 and the company operates the cable car of the same name on the summit of the Nebelhorn in the Allgäu Alps. The Nebelhornbahn has been in operation since 1930 and has been renewed and renovated several times since then. The core business of the Nebelhornbahn-AG is the operation of the Nebelhorn mountain railway as well as the associated catering businesses in Oberstdorf. The Nebelhorn is a popular excursion destination and offers a wide range of hiking, touring and climbing opportunities in summer and a large, snow-covered ski area in winter. The region in the Allgäuer Alps stands out as the highest ski area in the Allgäu, with the mountain railway carrying more than 450,000 guests to the Nebelhorn every year.

Since autumn 2019, the current renewal of the Nebenhornbahn is already underway and the first construction measures for the new main lift have been successfully completed. Following the decision in May 2020 to accelerate the implementation of this major project, construction activities were also intensified in the current financial year. Starting in the 2021/2022 financial year, the analysts at GBC Research expect regular business operations to resume during the summer and winter seasons. For this financial period, they forecast sales revenues of EUR 13.23 million and a net profit of EUR 0.58 million. Based on their forecasts for the current financial year and subsequent years, the experts have lowered the price target for Nebelhornbahn-AG from EUR 50.02 to EUR 45.60 per share.

Sales and earnings forecast raised

Founded in 1995, the SYZYGY Group is one of the leading consulting and implementation partners for the transformation in marketing and sales. SYZYGY creates, orchestrates and designs digital experiences and products for brands, companies and people. Strategy, products and activation are the central services of the group. Technology is the connecting and scaling element. The main focus of activities lies in strategic consulting, conception and design, technical realisation of brand platforms, business applications, websites, hosting, digital campaigns and mobile apps. Performance marketing and media services such as media planning, search engine marketing and optimisation also represent an important business area. Digital illustrations, virtual reality (VR) and augmented reality (AR) as well as animations complete the range of services.

As expected, the effects of the Covid-19 pandemic have also left their mark on SYZYGY AG. In the first half of 2020, sales declined by -14.6 % to EUR 26.95 million (previous year: EUR 31.57 million). In the second quarter, which was particularly affected by the pandemic, the company even recorded a decline in sales of -24.1 %. However, the SYZYGY management has confirmed its forecasts for the current financial year 2020. For the second half of 2020, the business environment is expected to improve overall and the analysts of GBC Research have therefore slightly raised their previous forecasts for 2020. As part of their DCF valuation model, they have raised their previous price target from EUR 9.25 to EUR 9.40 and continue to assign a 'Buy' rating.


Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

25. September 2020 | 12:24 CET

K+S, Grenke, Desert Gold: When does uncertainty become an opportunity?

  • Investments

When shares make losses over weeks and months, shareholders hope for an end to the sell-off. Potential buyers ask themselves whether the investment opportunity has already arisen. But the end of a downward trend can always only be determined afterward and can hardly ever be determined exactly. Rather, investors must shed light on the background to a price decline to decide whether it is permanent or merely temporary. The K+S fertilizer group has already been selling off for many years - on a five-year horizon a loss of more than 80% has been recorded - but what is the reason for this?

Read

23. September 2020 | 14:13 CET

Deutsche Bank, Daimler, Triumph Gold: What about these fallen angels?

  • Investments

When investigative journalists immerse themselves in the world of business, the name of Deutsche Bank is mentioned more and more often. Despite countless legal disputes and fines in recent years, the news flow does not end, the latest accusations being activities that observers call money laundering. The documentation surrounding the business relationship between Donald Trump and Deutsche Bank has cast what was once the world's largest financial institution, in a bad light. Although Trump had owed money to one department of the bank for a long time, another department of the bank lent money to the then dazzling real estate mogul to pay off his debts. Many investors would certainly not have thought that such a transaction, based on the principle of right pocket to left pocket would be possible at all. Deutsche Bank rejected a comment on the above-mentioned incident concerning banking secrecy.

Read

22. September 2020 | 09:20 CET

Almonty, BASF, Bayer: where is it worth starting now?

  • Investments

The start of the week was marked by price losses. In Europe and North America, the leading indices closed in the red. The fear of further effects of the Corona Pandemic has dampened market sentiment. Given that the banknote presses are still running, the breather on the capital markets is again likely to be short-lived. At the time when a vaccine against Covid-19 receives approval, the economy will once again experience an unleashed boom - provided that people can and may want to return to their jobs. Which shares are worthwhile now?

Read